<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Clemmensen TS</submitter><pubmed_abstract>&lt;h4>Aims&lt;/h4>The aim of this study was to evaluate left ventricular global longitudinal strain (LVGLS), N-terminal pro brain natriuretic peptide (Nt-ProBNP), and Troponin T as non-invasive markers for acute cellular rejection (ACR) diagnosis and severity assessment after heart transplantation (HTx).&lt;h4>Methods&lt;/h4>We retrospectively included all HTx patients transplanted from 2013 to 2019. At each visit, the patients were subjected to endomyocardial biopsy (EMB), measurement of Nt-ProBNP and Troponin T, and protocoled echocardiography with assessment of LVGLS. Sudden drop in graft function (SDGF) was defined as a drop in LVGLS ≥-2% in combination with either an increase in Troponin T ≥20% or Nt-ProBNP ≥30% compared with levels at the latest visit.&lt;h4>Results&lt;/h4>We included 1,436 EMBs from</pubmed_abstract><journal>Frontiers in immunology</journal><pagination>841849</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8990963</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Assessment of Acute Rejection by Global Longitudinal Strain and Cardiac Biomarkers in Heart-Transplanted Patients.</pubmed_title><pmcid>PMC8990963</pmcid><pubmed_authors>Olawi FM</pubmed_authors><pubmed_authors>Eiskjær H</pubmed_authors><pubmed_authors>Logstrup BB</pubmed_authors><pubmed_authors>Poulsen SH</pubmed_authors><pubmed_authors>Clemmensen TS</pubmed_authors><pubmed_authors>Firooznia N</pubmed_authors></additional><is_claimable>false</is_claimable><name>Assessment of Acute Rejection by Global Longitudinal Strain and Cardiac Biomarkers in Heart-Transplanted Patients.</name><description>&lt;h4>Aims&lt;/h4>The aim of this study was to evaluate left ventricular global longitudinal strain (LVGLS), N-terminal pro brain natriuretic peptide (Nt-ProBNP), and Troponin T as non-invasive markers for acute cellular rejection (ACR) diagnosis and severity assessment after heart transplantation (HTx).&lt;h4>Methods&lt;/h4>We retrospectively included all HTx patients transplanted from 2013 to 2019. At each visit, the patients were subjected to endomyocardial biopsy (EMB), measurement of Nt-ProBNP and Troponin T, and protocoled echocardiography with assessment of LVGLS. Sudden drop in graft function (SDGF) was defined as a drop in LVGLS ≥-2% in combination with either an increase in Troponin T ≥20% or Nt-ProBNP ≥30% compared with levels at the latest visit.&lt;h4>Results&lt;/h4>We included 1,436 EMBs from</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-05-18T12:06:15.163Z</modification><creation>2025-05-18T12:06:15.163Z</creation></dates><accession>S-EPMC8990963</accession><cross_references><pubmed>35401567</pubmed><doi>10.3389/fimmu.2022.841849</doi></cross_references></HashMap>